Drug Patent Watch
SEPTEMBER 22, 2020
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch can help you replace or supplement your current solutions with:…. The post Switching to DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
SEPTEMBER 23, 2020
Sixfold Bioscience and Medicines Discovery Catapult awarded Innovate UK grant to pursue ground-breaking project. Sixfold Bioscience in partnership with Medicines Discovery Catapult, has been given the green light, through the award of an Innovate UK Smart Grant to test a pioneering system designed to deliver drugs directly to cancerous cells, without impacting the healthy cells around it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Times
SEPTEMBER 19, 2020
Experts are concerned that the company has not been more forthcoming about two participants who became seriously ill after getting its experimental vaccine.
Pharma in Brief
SEPTEMBER 22, 2020
On September 16, 2020, the Minister of Health signed an Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 (the Interim Order ) which provides new regulatory pathways to expedite the approval of COVID-19 drugs and vaccines that have not yet been approved for sale in Canada. It also allows for addition of new indications related to COVID-19 that are not included in a currently-marketed product’s authorization.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
SEPTEMBER 25, 2020
Annual Drug Patent Expirations for KORLYM Korlym is a drug marketed by Corcept Therap and is included in one NDA. There are thirteen patents protecting this drug and one Paragraph…. The post New patent for Corcept Therap drug KORLYM appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
SEPTEMBER 23, 2020
Life science companies must evolve and find new ways of working that erase the lines between industries and sub-sectors if they are to adapt to the digitalised world. That’s according to the team at Sweden’s Sahlgrenska Science Park, who are getting ready to host a virtual event looking at how the specialisation of digital expertise is driving a trend of sector convergence that pharma is only just cottoning on to.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
SEPTEMBER 21, 2020
While scientists are rushing to develop an immunization for adults, no one has started the process yet for children.
Pharma Times
SEPTEMBER 24, 2020
UK-headquartered company will characterise autoantibody profiles of clinical trial patients
pharmaphorum
SEPTEMBER 21, 2020
Compass Pathways and its potential magic mushroom depression drug went public last week – and now psychedelic therapy firm Mind Medicine is aiming to follow suit by up-listing its shares on the Nasdaq. UK-based Compass has a patented synthetic version of psilocybin, the active ingredient in magic mushrooms, and raised around $127.5 million with its IPO on Friday and shares are still significantly above their launch price of $17.
Drug Patent Watch
SEPTEMBER 24, 2020
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are sixteen patents protecting this drug. XHANCE drug…. The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
NY Times
SEPTEMBER 23, 2020
Unlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two.
Pharma Times
SEPTEMBER 23, 2020
European Medicines Agency grants designation based on phase I/II data
pharmaphorum
SEPTEMBER 24, 2020
A potential COVID-19 breath test has been unveiled in the UK, as the country desperately searches for alternatives to crippling lockdown measures to prevent the disease from spreading. The breath test has been developed by Integumen in collaboration with Modern Water, Avacta and Aptamer Group, which had been working on test that identifies the SARS-CoV-2 coronavirus in waste water.
Outsourcing Pharma
SEPTEMBER 21, 2020
A leader from the pharma software solutions provider suggests streamlining communication between shifts can avoid manufacturing snags.
NY Times
SEPTEMBER 23, 2020
Benzodiazepines — commonly prescribed for anxiety, insomnia, seizures and panic disorders — are highly addictive and come with health risks, especially when combined with other drugs.
Pharma Times
SEPTEMBER 21, 2020
Positive opinions include Pacira's Exparel and two new vaccines from Sanofi
pharmaphorum
SEPTEMBER 21, 2020
Amazon’s Alexa device can already field health and medical questions, but the library of responses has now been bulked up thanks to a partnership with digital health company Sharecare. The new deal adds more than 80,000 questions and answers to the repertoire of the Alexa virtual assistant, which provides information, entertainment and advice to users on voice command via devices such as Amazon’s Echo smart speakers.
Pharma Mirror
SEPTEMBER 25, 2020
The Hague — Governments and other stakeholders must take urgent action to ensure equity in access to disease prevention measures, which includes greater investment in vaccines and vaccination services by community pharmacists. So said the International Pharmaceutical Federation (FIP) in a call to action made today at the start of a new FIP Digital Programme to.
NY Times
SEPTEMBER 24, 2020
The U.S. insisted that new international guidelines on combating drug resistance omit any mention of fungicides — a demand that the industry made but that ran counter to science.
Pharma Times
SEPTEMBER 21, 2020
Detailed results presented at ESMO also show benefit in prostate cancer
pharmaphorum
SEPTEMBER 24, 2020
An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. The ASD diagnostic app is designed to serve as a tool that can be used by paediatricians in primary care to detect autism traits early on and start treatment sooner.
Drug Patent Watch
SEPTEMBER 25, 2020
Annual Drug Patent Expirations for EPANED Epaned is a drug marketed by Azurity and Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are…. The post New patent for Azurity drug EPANED appeared first on DrugPatentWatch - Make Better Decisions.
NY Times
SEPTEMBER 21, 2020
There is accumulating evidence that the benefits of statins far outweigh possible risks, and nearly all statins on the market are now available as inexpensive generics.
Pharma Times
SEPTEMBER 22, 2020
Data presented at 2020 ESMO virtual congress
pharmaphorum
SEPTEMBER 24, 2020
Although life for the general public is (slowly) starting to edge back towards normality, healthcare providers are still on a heightened state of alert. In the UK, the 1 August step down from EPRR incident level four may have meant we’re no longer in a state of national incident, but at a regional level NHS Trusts and private sector providers are still very much working flat out to manage and contain COVID-19 and its associated fallout.
Drug Patent Watch
SEPTEMBER 25, 2020
Annual Drug Patent Expirations for PLENVU Plenvu is a drug marketed by Salix and is included in one NDA. It is available from one supplier. There are six patents protecting…. The post New patent for SALIX drug PLENVU appeared first on DrugPatentWatch - Make Better Decisions.
NY Times
SEPTEMBER 19, 2020
After announcing the first government clearance for a coronavirus vaccine, Russia delayed distributing it. It remains unclear how many people have received it.
Pharma Times
SEPTEMBER 23, 2020
Upfront funding will be used to scale-up manufacturing
pharmaphorum
SEPTEMBER 22, 2020
A UK university has struck a partnership with medical technology firm Better that aims to give nursing and pharmacy students a better insight into e-prescribing. Liverpool John Moores University is to use Better’s OPENeP electronic prescribing and medicines administration software to teach the students about modern prescribing practices. OPENeP is designed as a stand-alone product that allows electronic patient record systems to be integrated with medication-related decision support systems.
Drug Patent Watch
SEPTEMBER 24, 2020
Annual Drug Patent Expirations for MARQIBO+KIT Marqibo Kit is a drug marketed by Acrotech and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent expiration for Acrotech drug MARQIBO KIT appeared first on DrugPatentWatch - Make Better Decisions.
NY Times
SEPTEMBER 23, 2020
For chronically ill patients, decisions about whether to pay or go without medications are life-or-death battles that must be fought over and over again.
Pharma Times
SEPTEMBER 23, 2020
Study detected Nonalcoholic Fatty Liver Disease and Nonalcoholic steatohepatitis
pharmaphorum
SEPTEMBER 22, 2020
New research from The Patients Association, supported through sponsorship provided by Novo Nordisk and ENGINE MHP, looks at how more than 950 patients experienced the COVID-19 pandemic, with an emphasis on managing and accessing care and their experiences of treatment and services more broadly. Here, Patients Association CEO Rachel Power and ENGINE MHP director Jonathon Sheppard explore some of the findings – such as major disruptions to the relationships between patients and the health and care
Drug Patent Watch
SEPTEMBER 24, 2020
Annual Drug Patent Expirations for INVEGA+SUSTENNA Invega Sustenna is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…. The post New patent for Janssen Pharms drug INVEGA SUSTENNA appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
SEPTEMBER 23, 2020
Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialty pharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialty drugs. See below for detailed data on oncology and non-oncology products.
Expert insights. Personalized for you.
145 
Let's personalize your content